Lake Street Sets Buy on Treace Medical, Targets $14.50 Lake Street Capital initiates Treace Medical with a Buy rating and a $14.50 price target, anticipating portfolio expansions. Learn more about this investment opportunity.
Lake Street Initiates Buy Rating for Treace Medical Lake Street starts coverage on Treace Medical (TMCI) with a Buy rating and $14.50 price target. Anticipates significant portfolio growth by 2025.